2026-11-06

Arm Holdings Beat on Revenue (+27%) and EPS (+33%), But the Stock Fell 11% - Here's the Line That Spooked Wall Street

Written & reviewed by the TradeSmrt editorial team · 2026-11-06

In this article

What Happened
The Mechanism Behind the Drop
What to Take Away From This
FAQ
Sources

What Happened

After the closing bell on Wednesday, November 4, British chip designer Arm Holdings (NASDAQ: ARM) reported fiscal second-quarter 2027 results (covering July through September 2026), and on paper, it looked like a clean beat. Revenue rose 27% year over year to $1.443 billion, while adjusted earnings per share came in at $0.52, up 33% from a year earlier. Both figures cleared Wall Street's consensus estimates by a wide margin - analysts had modeled revenue around $1.38 billion and EPS near $0.47. Licensing revenue, the business line that lets chipmakers pay upfront for the right to use Arm's designs, surged 50% year over year to $773 million, driven by new Arm Total Access (ATA) and Compute Subsystems (CSS) agreements.

Then, the very next day, Thursday, November 5, Arm's stock fell as much as 12% intraday and closed down roughly 11%. Shares that had traded near $220 before the report slid into the low $190s by the close - a level that, measured against the stock's 2025 high of $337, puts it close to cutting its value in half. A company that beat on both of Wall Street's two headline metrics still watched its stock drop by double digits in a single session, and the explanation was buried a few lines down the income statement, in the royalty revenue figure.

Arm's royalty revenue - the fee it collects per chip actually shipped using its designs, and the cleanest available signal of real-world demand - came in at $670 million, up just 8% from $620 million a year earlier. Barclays and other analysts had modeled royalty growth of roughly 14% or more. Several analysts pointed to softness in the Android smartphone ecosystem as the main driver of that shortfall. Mobile application processors alone made up about 43% of Arm's total royalty revenue in fiscal 2026, making this a hit to the company's single largest demand-side segment. Guidance for the next quarter didn't reassure investors either: Arm guided fiscal third-quarter revenue to roughly $1.54 billion, only barely above the roughly $1.53 billion consensus.

The Mechanism Behind the Drop

The core of this story is that Arm's two revenue streams - licensing and royalties - were sending opposite signals in the same earnings report. Licensing revenue is money a chipmaker pays upfront for the right to use Arm's designs in future products; it gets booked as revenue the moment a contract is signed, so a single large deal can swing the number sharply in any given quarter. Royalty revenue, by contrast, flows in proportion to how many chips using those designs are actually manufactured and shipped. In other words, licensing revenue measures a promise about the future, while royalty revenue measures what's actually happening right now.

This quarter's results pointed in two different directions at once, and that divergence is exactly what unsettled investors. A 50% jump in licensing revenue is unambiguously good news, but it's a forward-looking commitment, not realized demand. An 8% royalty growth rate, on the other hand, is a colder, more immediate signal that Arm-based chips are selling into the Android ecosystem more slowly than expected, right now. Investors weighted that second signal more heavily because licensing contracts only pay off if they eventually convert into royalty revenue a few years down the line - and a slowdown in royalty growth today raises doubts about whether that conversion cycle is on track.

Uncertainty around Arm's AGI CPU business, its in-house push into AI data-center chips, compounded the reaction. On the earnings call, management said it saw "upside" to its stated target of more than $1 billion in AGI CPU revenue, but stopped short of formally raising that target. Arm unveiled the AGI CPU in March with Meta as its debut customer, marking a genuine departure from the pure licensing model the company has run for decades - and the market had already priced in a fair amount of optimism about that pivot. A vague mention of "upside" rather than a concrete number fell short of the confirmation investors were looking for.

Arm's slide also landed in the same week as Qualcomm's 26% handset revenue decline, reported just one day earlier. Two large chip companies stumbling for different reasons in the same stretch of days amplified a broader anxiety that something was wrong across the whole semiconductor sector - a worry that helped fuel the wider chip-stock selloff that hit Nvidia, AMD, and Intel on November 5, even though neither of those companies had reported disappointing news of their own that week.

What to Take Away From This

Headline revenue and EPS beats don't guarantee a stock will rise. Arm cleared both consensus numbers by a wide margin and still fell double digits. What mattered more was the composition beneath those numbers - specifically, whether the underlying demand signal (royalties) matched the growth story investors had been pricing in.
When a company has two distinct revenue lines, separate them before drawing conclusions. Licensing revenue is a leading indicator of future growth; royalty revenue is a coincident indicator of current demand. A strong leading indicator paired with a weak coincident one is a genuine warning sign, not a wash.
Vague management commentary on new ventures can disappoint when expectations are already priced in. Saying there's "upside" to a target, without raising the target itself, often reads as management declining to commit - and markets tend to punish that ambiguity more harshly for businesses already trading on optimism.
Sector-wide selloffs often start with two or three unrelated company-specific misses landing close together. Arm's royalty miss and Qualcomm's handset decline hit in the same week for entirely different reasons, yet together they created a narrative that dragged down chip stocks with no bad news of their own.

FAQ

What's the actual difference between Arm's licensing revenue and royalty revenue?

Licensing revenue is the upfront fee a chipmaker pays for the right to use Arm's designs in future products, and it's recognized the moment a contract is signed. Royalty revenue is the per-chip fee Arm collects on products that have actually been manufactured and shipped using its designs. The first reflects future growth expectations; the second reflects current, real-world demand.

Why does Android smartphone demand matter so much to Arm's results?

Mobile application processors - the chips that power smartphones - made up roughly 43% of Arm's total royalty revenue in fiscal 2026, making them the single largest driver of that revenue line. When Android device shipments or chip orders soften, it shows up directly and immediately in Arm's royalty growth rate, which is exactly what analysts say happened this quarter.

What is Arm's AGI CPU, and why does it matter for the stock?

The AGI CPU is Arm's first in-house-designed chip for AI data centers, unveiled in March 2026 with Meta as its first customer. It represents a shift away from Arm's decades-old pure-licensing business model toward designing and bringing its own silicon to market. Management has said the data-center CPU market could be worth more than $1 trillion to Arm through 2030, which is why investors reacted to the lack of a formally raised revenue target on this quarter's call.

Sources

This article is an independent synthesis and analysis based on the reporting below, not a reproduction of the original articles. Please check the original sources directly for the most current figures.

⚠️ This article is for informational purposes only and is not investment advice. Market conditions change constantly, so always verify the latest data before making investment decisions.